만성 간질환 환자에서 혈청 CA 125의 임상적 의의
Clinical Significance of Serum CA 125 in Patients with Chronic Liver Diseases
소속 상세정보
김영신/Kim YS
김도영/유금혜/송지현/김명신/정해선/박지영/정혜경/유권/문일환/백진영/Kim DY/Ryu KH/Song JH/Kim MS/Jung HS/Park JY/Jung HK/Yoo K/Moon IH/Baek JY
KMID : 0614620030420050409
Abstract
BACKGROUND/AIMS: The clinical significance of serum CA 125 levels in patients with chronic liver disease has not been widely appreciated in relation to the severity of the disease. We examined serum CA 125 levels in patients with chronic liver disease according to the severity of liver disease and the presence of ascites.
METHODS: Fasting serum CA 125 levels were measured by a commercial RIA kit in 92 patients with chronic liver disease: 22 with chronic hepatitis and 70 with liver cirrhosis (Child class A, 19; B, 28; C, 23). Forty-one patients (45%) had ascites.
RESULTS: The patients with Child class C liver cirrhosis had significantly higher mean serum CA 125 level than those with class A (p<0.05). In Child class B patients, the mean serum CA 125 level was significantly higher in patients with ascites than in those without (p<0.05). A multiple regression analysis showed that the presence of ascites, serum albumin, and prothrombin time were independent factors related to the increase of serum CA 125 levels.
CONCLUSIONS: The presence of ascites is more closely related to the increase of CA125 levels in patients with liver cirrhosis than the severity of liver disease.
키워드
CA 125; 만성 간질환; 간경변증; 복수; CA 125 antigen; Hepatitis; chronic; Liver cirrhosis; Ascites
원문 및 링크아웃 정보
등재저널 정보